Teladoc, Inc. (TDOC) Insider Sells $1,663,681.52 in Stock
Teladoc, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 53,806 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $30.92, for a total transaction of $1,663,681.52. Following the completion of the transaction, the insider now directly owns 33,008 shares of the company’s stock, valued at $1,020,607.36. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Shares of Teladoc, Inc. (NYSE:TDOC) opened at 30.70 on Friday. The company’s market capitalization is $1.74 billion. Teladoc, Inc. has a 12-month low of $14.00 and a 12-month high of $36.90. The stock’s 50 day moving average is $34.01 and its 200-day moving average is $27.44.
Teladoc (NYSE:TDOC) last issued its earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by $0.02. Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The company had revenue of $44.60 million for the quarter, compared to the consensus estimate of $44.39 million. During the same quarter in the prior year, the company posted ($0.38) EPS. Teladoc’s revenue was up 68.3% compared to the same quarter last year. Analysts anticipate that Teladoc, Inc. will post ($1.47) earnings per share for the current year.
Several institutional investors have recently modified their holdings of the company. Great West Life Assurance Co. Can bought a new position in shares of Teladoc during the first quarter worth $105,000. US Bancorp DE raised its position in shares of Teladoc by 10.3% in the first quarter. US Bancorp DE now owns 4,617 shares of the health services provider’s stock worth $116,000 after buying an additional 433 shares in the last quarter. Bank of Montreal Can raised its position in shares of Teladoc by 214.2% in the second quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock worth $123,000 after buying an additional 2,397 shares in the last quarter. Pacad Investment Ltd. bought a new position in shares of Teladoc during the second quarter worth $135,000. Finally, Legal & General Group Plc raised its position in shares of Teladoc by 66.3% in the first quarter. Legal & General Group Plc now owns 6,137 shares of the health services provider’s stock worth $154,000 after buying an additional 2,446 shares in the last quarter. Hedge funds and other institutional investors own 95.88% of the company’s stock.
Several brokerages have commented on TDOC. Cantor Fitzgerald reissued a “hold” rating and issued a $27.00 price target on shares of Teladoc in a report on Monday, June 19th. Canaccord Genuity reissued a “buy” rating and issued a $42.00 price target (up from $34.00) on shares of Teladoc in a report on Tuesday, June 20th. William Blair reissued an “outperform” rating on shares of Teladoc in a report on Tuesday, June 20th. Chardan Capital raised their price target on shares of Teladoc from $30.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, June 20th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $32.00 price target on shares of Teladoc in a report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $35.55.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Stock Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related stocks with our FREE daily email newsletter.